zarelis retard 150 mg comprimidos de liberacion prolongada
italfarmaco s.a. - venlafaxina hidrocloruro - comprimido de liberaciÓn prolongada - 150 mg - venlafaxina hidrocloruro 150 mg - venlafaxina
zarelis retard 225 mg comprimidos de liberacion prolongada
italfarmaco s.a. - venlafaxina hidrocloruro - comprimido de liberaciÓn prolongada - 225 mg - venlafaxina hidrocloruro 225 mg - venlafaxina
zarelis retard 75 mg comprimidos de liberacion prolongada
italfarmaco s.a. - venlafaxina hidrocloruro - comprimido de liberaciÓn prolongada - 75 mg - venlafaxina hidrocloruro 75 mg - venlafaxina
zarelis retard 300 mg comprimidos de liberacion prolongada
italfarmaco s.a. - venlafaxina hidrocloruro - comprimido de liberaciÓn prolongada - 300 mg - venlafaxina hidrocloruro 300 mg - venlafaxina
degarelix accord
accord healthcare s.l.u. - degarelix acetate - neoplasmas prostáticos - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
zarelis retard 75 mg 30 compr lib perllongada
zarelis retard 150 mg 30 comprim alliber perllongada
zarelis retard 225 mg 30 comprim alliber perllongada
firmagon
ferring pharmaceuticals a/s - degarelix - neoplasmas prostáticos - terapia endocrina - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
firmagon liofilizado para solución inyectable 120 mg con solvente (degarelix)
ferring productos farmacÉuticos spa - degarelix - sin formulas